UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Sunflower Bank N.A.

24 Dec 2023, 14:44 by Kim Johansen · The Markets Daily

Sunflower Bank N.A. cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,458 shares of the healthcare conglomerate’s stock after selling 46 shares during the quarter. Sunflower Bank N.A.’s holdings in UnitedHealth Group were worth $735,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in UNH. Bank Julius Baer & Co. Ltd Zurich lifted its stake in UnitedHealth Group by 97,436.9% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,029,274,230 shares of the healthcare conglomerate’s stock worth $494,710,366,000 after purchasing an additional 1,028,218,963 shares during the last quarter. Moneta Group Investment Advisors LLC lifted its stake in UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares during the last quarter. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter worth $5,210,004,000. Osaic Holdings Inc. lifted its stake in UnitedHealth Group by 776.9% in the second quarter. Osaic Holdings Inc. now owns 3,248,409 shares of the healthcare conglomerate’s stock valued at $177,941,000 after buying an additional 2,877,983 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its stake in UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after buying an additional 2,540,538 shares during the last quarter. 85.69% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 4,498 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares of the company’s stock, valued at $5,017,173.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stephen J. Hemsley sold 121,515 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $540.58, for a total value of $65,688,578.70. Following the sale, the director now directly owns 521,818 shares of the company’s stock, valued at approximately $282,084,374.44. The disclosure for this sale can be found here. In the last quarter, insiders sold 192,094 shares of company stock valued at $104,507,072. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $520.31 on Friday. The company has a market capitalization of $481.25 billion, a price-to-earnings ratio of 22.58, a P/E/G ratio of 1.57 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.80 and a quick ratio of 0.80. The business’s 50-day moving average is $536.71 and its 200-day moving average is $507.70.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share for the quarter, beating analysts’ consensus estimates of $6.33 by $0.23. The company had revenue of $92.36 billion for the quarter, compared to the consensus estimate of $91.41 billion. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.79 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 24.95 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, December 4th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, December 1st. This represents a $7.52 annualized dividend and a dividend yield of 1.45%. UnitedHealth Group’s payout ratio is 32.64%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday, November 21st. Stephens restated an “overweight” rating and set a $585.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, December 13th. Morgan Stanley lowered their target price on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a report on Monday, October 23rd. Jefferies Financial Group lowered their target price on UnitedHealth Group from $565.00 to $503.00 and set a “hold” rating on the stock in a report on Monday, November 20th. Finally, Truist Financial reaffirmed a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Thursday, November 30th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $574.89.

Check Out Our Latest Analysis on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.